- Home
- ACIU vs PMTS Comparison
ACIU vs PMTS Comparison
Compare ACIU & PMTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- PMTS
- Stock Information
- Founded
- ACIU 2003
- PMTS 2007
- Country
- ACIU Switzerland
- PMTS United States
- Employees
- ACIU N/A
- PMTS N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- PMTS Finance Companies
- Sector
- ACIU Health Care
- PMTS Finance
- Exchange
- ACIU Nasdaq
- PMTS Nasdaq
- Market Cap
- ACIU 213.3M
- PMTS 183.1M
- IPO Year
- ACIU 2016
- PMTS 2015
- Fundamental
- Price
- ACIU $2.90
- PMTS $15.09
- Analyst Decision
- ACIU Strong Buy
- PMTS Strong Buy
- Analyst Count
- ACIU 2
- PMTS 4
- Target Price
- ACIU $10.00
- PMTS $34.00
- AVG Volume (30 Days)
- ACIU 343.9K
- PMTS 36.3K
- Earning Date
- ACIU 11-04-2025
- PMTS 11-04-2025
- Dividend Yield
- ACIU N/A
- PMTS N/A
- EPS Growth
- ACIU N/A
- PMTS N/A
- EPS
- ACIU N/A
- PMTS 1.11
- Revenue
- ACIU $36,362,036.00
- PMTS $502,361,000.00
- Revenue This Year
- ACIU N/A
- PMTS $14.84
- Revenue Next Year
- ACIU $1,022.98
- PMTS $10.55
- P/E Ratio
- ACIU N/A
- PMTS $13.71
- Revenue Growth
- ACIU 86.71
- PMTS 14.31
- 52 Week Low
- ACIU $1.43
- PMTS $12.52
- 52 Week High
- ACIU $3.99
- PMTS $35.19
- Technical
- Relative Strength Index (RSI)
- ACIU 47.76
- PMTS 46.51
- Support Level
- ACIU $2.89
- PMTS $15.00
- Resistance Level
- ACIU $3.21
- PMTS $15.73
- Average True Range (ATR)
- ACIU 0.33
- PMTS 0.60
- MACD
- ACIU -0.08
- PMTS 0.03
- Stochastic Oscillator
- ACIU 3.95
- PMTS 32.11
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.